Detailed information for compound 1637052

Basic information

Technical information
  • TDR Targets ID: 1637052
  • Name: N-[5-(benzoylimino)-1,2,4-dithiazol-3-yl]benz amide
  • MW: 341.407 | Formula: C16H11N3O2S2
  • H donors: 1 H acceptors: 2 LogP: 3.81 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(c1ccccc1)/N=c/1\ss/c(=N\C(=O)c2ccccc2)/[nH]1
  • InChi: 1S/C16H11N3O2S2/c20-13(11-7-3-1-4-8-11)17-15-19-16(23-22-15)18-14(21)12-9-5-2-6-10-12/h1-10H,(H,17,18,19,20,21)
  • InChiKey: FJYFMVGZHDRPLR-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-[5-(oxo-phenylmethyl)imino-1,2,4-dithiazol-3-yl]benzamide
  • N-(5-phenylcarbonylimino-1,2,4-dithiazol-3-yl)benzamide
  • NCI60_006627

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Toxoplasma gondii hypothetical protein 0.0724 0.0823 0.9009
Trichomonas vaginalis conserved hypothetical protein 0.0724 0.0823 0.1545
Trichomonas vaginalis conserved hypothetical protein 0.0758 0.0896 0.1681
Trypanosoma cruzi cAMP specific phosphodiesterase, putative 0.1067 0.1563 0.517
Trypanosoma cruzi GAF domain/TIP41-like family, putative 0.1743 0.3024 1
Echinococcus multilocularis high affinity cAMP specific 3',5' cyclic 0.0682 0.0733 0.3212
Trichomonas vaginalis conserved hypothetical protein 0.281 0.5327 1
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Schistosoma mansoni high-affinity cgmp-specific 35-cyclic phosphodiesterase 0.0417 0.0159 0.0034
Loa Loa (eye worm) hypothetical protein 0.0934 0.1277 0.1166
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Echinococcus multilocularis dual 3',5' cyclic AMP and GMP phosphodiesterase 0.1067 0.1563 0.7862
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.1067 0.1563 0.2934
Trypanosoma cruzi cAMP specific phosphodiesterase, putative 0.1067 0.1563 0.517
Plasmodium falciparum GAF domain-related protein, putative 0.0724 0.0823 1
Loa Loa (eye worm) hypothetical protein 0.4973 1 1
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis cAMP-specific phosphodiesterase, putative 0.1067 0.1563 0.2934
Leishmania major hypothetical protein, conserved 0.1743 0.3024 1
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis cone cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis cGMP-inhibited 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Echinococcus granulosus high affinity cAMP specific 3'5' cyclic 0.0682 0.0733 0.3212
Toxoplasma gondii hypothetical protein 0.0758 0.0896 1
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis cAMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.1067 0.1563 0.2934
Toxoplasma gondii hypothetical protein 0.0724 0.0823 0.9009
Mycobacterium tuberculosis Conserved hypothetical protein 0.1743 0.3024 0.5847
Trypanosoma brucei GAF domain/TIP41-like family, putative 0.1743 0.3024 1
Trichomonas vaginalis cAMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.1067 0.1563 0.2934
Echinococcus granulosus cAMP and cAMP inhibited cGMP 3'5' cyclic 0.1243 0.1945 1
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1033 0.149 0.2797
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.2052 0.3691 0.6929
Trypanosoma cruzi GAF domain/TIP41-like family, putative 0.1743 0.3024 1
Mycobacterium ulcerans two component sensor histidine kinase DevS 0.2467 0.4587 1
Trichomonas vaginalis conserved hypothetical protein 0.0758 0.0896 0.1681
Schistosoma mansoni cgmp-dependent 35-cyclic phosphodiesterase 0.4973 1 1
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.281 0.5327 1
Toxoplasma gondii GAF domain-containing protein 0.0724 0.0823 0.9009
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.281 0.5327 1
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.1067 0.1563 0.2934
Plasmodium vivax hypothetical protein, conserved 0.0724 0.0823 0.5
Trichomonas vaginalis cone cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.1067 0.1563 0.2934
Mycobacterium leprae conserved hypothetical protein 0.0724 0.0823 0.5
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Schistosoma mansoni camp/cgmp cyclic nucleotide phosphodiesterase 0.1067 0.1563 0.1455
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.281 0.5327 1
Echinococcus multilocularis cAMP and cAMP inhibited cGMP 3',5' cyclic 0.1243 0.1945 1
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.2052 0.3691 0.6929
Trichomonas vaginalis cAMP/cGMP cyclic nucleotide phosphodiesterase, putative 0.1067 0.1563 0.2934
Echinococcus granulosus dual 3'5' cyclic AMP and GMP phosphodiesterase 0.1067 0.1563 0.7862
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trypanosoma cruzi cAMP specific phosphodiesterase, putative 0.1067 0.1563 0.517
Trichomonas vaginalis conserved hypothetical protein 0.0758 0.0896 0.1681
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis cAMP-specific phosphodiesterase, putative 0.1067 0.1563 0.2934
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.1033 0.149 0.2797
Brugia malayi Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative 0.1243 0.1945 0.1842
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.1033 0.149 0.2797
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1067 0.1563 0.2934
Mycobacterium tuberculosis Two component sensor histidine kinase DevS 0.2467 0.4587 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.